Clinical trial
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
NCT06803784 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
- Lead sponsor
- Neuromed IRCCS
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 4, 2025
- Completion date
- December 31, 2026
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease (ad), amyotrophic lateral sclerosis (als), frontotemporal dementia (ftd), parkinson disease